A new trading day began on Friday, with Dermata Therapeutics Inc (NASDAQ: DRMA) stock price up 11.11% from the previous day of trading, before settling in for the closing price of $2.52. DRMA’s price has ranged from $2.34 to $23.70 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 43.22% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 90.04%. With a float of $0.75 million, this company’s outstanding shares have now reached $0.84 million.
Dermata Therapeutics Inc (DRMA) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Dermata Therapeutics Inc is 26.85%, while institutional ownership is 8.99%.
Dermata Therapeutics Inc (DRMA) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -13.4 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.72 per share during the current fiscal year.
Dermata Therapeutics Inc (NASDAQ: DRMA) Trading Performance Indicators
Here are Dermata Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.56.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -20.29, a number that is poised to hit -1.54 in the next quarter and is forecasted to reach -3.01 in one year’s time.
Technical Analysis of Dermata Therapeutics Inc (DRMA)
Let’s dig in a bit further. During the last 5-days, its volume was 0.54 million. That was better than the volume of 0.1 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 53.10%.
During the past 100 days, Dermata Therapeutics Inc’s (DRMA) raw stochastic average was set at 8.91%, which indicates a significant decrease from 56.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.28 in the past 14 days, which was lower than the 0.40 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.68, while its 200-day Moving Average is $6.80. However, in the short run, Dermata Therapeutics Inc’s stock first resistance to watch stands at $2.96. Second resistance stands at $3.13. The third major resistance level sits at $3.34. If the price goes on to break the first support level at $2.59, it is likely to go to the next support level at $2.38. Assuming the price breaks the second support level, the third support level stands at $2.21.
Dermata Therapeutics Inc (NASDAQ: DRMA) Key Stats
With a market capitalization of 2.87 million, the company has a total of 1,026K Shares Outstanding. Currently, annual sales are 0 K while annual income is -12,290 K. The company’s previous quarter sales were 0 K while its latest quarter income was -1,690 K.
